Literature DB >> 36161923

Human neutrophil peptides 1-3 protect the murine urinary tract from uropathogenic Escherichia coli challenge.

Jorge J Canas1,2, Dong Liang1, Vijay Saxena1, Jenaya Hooks1, Samuel W Arregui1, Hongyu Gao3, Yunlong Liu3, Danielle Kish4, Sarah C Linn5, Khalil Bdeir6,7, Douglas B Cines6,7, Robert L Fairchild4, John D Spencer8, Andrew L Schwaderer1,9, David S Hains1,2,9.   

Abstract

Antimicrobial peptides (AMPs) are critical to the protection of the urinary tract of humans and other animals from pathogenic microbial invasion. AMPs rapidly destroy pathogens by disrupting microbial membranes and/or augmenting or inhibiting the host immune system through a variety of signaling pathways. We have previously demonstrated that alpha-defensins 1-3 (DEFA1A3) are AMPs expressed in the epithelial cells of the human kidney collecting duct in response to uropathogens. We also demonstrated that DNA copy number variations in the DEFA1A3 locus are associated with UTI and pyelonephritis risk. Because DEFA1A3 is not expressed in mice, we utilized human DEFA1A3 gene transgenic mice (DEFA4/4) to further elucidate the biological relevance of this locus in the murine urinary tract. We demonstrate that the kidney transcriptional and translational expression pattern is similar in humans and the human gene transgenic mouse upon uropathogenic Escherichia coli (UPEC) stimulus in vitro and in vivo. We also demonstrate transgenic human DEFA4/4 gene mice are protected from UTI and pyelonephritis under various UPEC challenges. This study serves as the foundation to start the exploration of manipulating the DEFA1A3 locus and alpha-defensins 1-3 expression as a potential therapeutic target for UTIs and other infectious diseases.

Entities:  

Keywords:  antimicrobial peptides; collecting ducts; molecular biology; pyelonephritis; transgenic mouse

Mesh:

Substances:

Year:  2022        PMID: 36161923      PMCID: PMC9546544          DOI: 10.1073/pnas.2206515119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  42 in total

1.  Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity.

Authors:  Theresa L Chang; Jesus Vargas; Armando DelPortillo; Mary E Klotman
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

2.  Alpha-defensin DEFA1A3 gene copy number elevation in Danish Crohn's disease patients.

Authors:  Cathrine Jespersgaard; Peder Fode; Marianne Dybdahl; Ida Vind; Ole Haagen Nielsen; Claudio Csillag; Pia Munkholm; Ben Vainer; Lene Riis; Margarita Elkjaer; Natalia Pedersen; Elisabeth Knudsen; Paal Skytt Andersen
Journal:  Dig Dis Sci       Date:  2011-06-24       Impact factor: 3.199

Review 3.  A role for collecting duct epithelial cells in renal antibacterial defences.

Authors:  Cecilia Chassin; Emilie Tourneur; Marcelle Bens; Alain Vandewalle
Journal:  Cell Microbiol       Date:  2011-05-25       Impact factor: 3.715

4.  Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins.

Authors:  Katherine Miles; David J Clarke; Wuyuan Lu; Zaneta Sibinska; Paula E Beaumont; Donald J Davidson; Tom A Barr; Dominic J Campopiano; Mohini Gray
Journal:  J Immunol       Date:  2009-07-13       Impact factor: 5.422

5.  Polymorphisms in α-Defensin-Encoding DEFA1A3 Associate with Urinary Tract Infection Risk in Children with Vesicoureteral Reflux.

Authors:  Andrew L Schwaderer; Huanyu Wang; SungHwan Kim; Jennifer M Kline; Dong Liang; Pat D Brophy; Kirk M McHugh; George C Tseng; Vijay Saxena; Evan Barr-Beare; Keith R Pierce; Nader Shaikh; J Robert Manak; Daniel M Cohen; Brian Becknell; John D Spencer; Peter B Baker; Chack-Yung Yu; David S Hains
Journal:  J Am Soc Nephrol       Date:  2016-03-03       Impact factor: 10.121

6.  Developmental loss, but not pharmacological suppression, of renal carbonic anhydrase 2 results in pyelonephritis susceptibility.

Authors:  John Ketz; Vijay Saxena; Samuel Arregui; Ashley Jackson; George J Schwartz; Takafumi Yagisawa; Robert L Fairchild; David S Hains; Andrew L Schwaderer
Journal:  Am J Physiol Renal Physiol       Date:  2020-05-11

7.  Expression and antimicrobial function of beta-defensin 1 in the lower urinary tract.

Authors:  Brian Becknell; John David Spencer; Ashley R Carpenter; Xi Chen; Aspinder Singh; Suzanne Ploeger; Jennifer Kline; Patrick Ellsworth; Birong Li; Ehrhardt Proksch; Andrew L Schwaderer; David S Hains; Sheryl S Justice; Kirk M McHugh
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

Review 8.  An evolutionary history of defensins: a role for copy number variation in maximizing host innate and adaptive immune responses.

Authors:  Lee R Machado; Barbara Ottolini
Journal:  Front Immunol       Date:  2015-03-18       Impact factor: 7.561

9.  Low-Copy Number Polymorphism in DEFA1/DEFA3 Is Associated with Susceptibility to Hospital-Acquired Infections in Critically Ill Patients.

Authors:  Jialian Zhao; Qiang Gu; Lifeng Wang; Weize Xu; Lihua Chu; Ya Wang; Zhongwang Li; Shuijing Wu; Jianguo Xu; Zhiyong Hu; Qiang Shu; Xiangming Fang
Journal:  Mediators Inflamm       Date:  2018-05-22       Impact factor: 4.711

10.  Whole Transcriptome Analysis of Renal Intercalated Cells Predicts Lipopolysaccharide Mediated Inhibition of Retinoid X Receptor alpha Function.

Authors:  Vijay Saxena; James Fitch; John Ketz; Peter White; Amy Wetzel; Melinda A Chanley; John D Spencer; Brian Becknell; Keith R Pierce; Sam W Arregui; Raoul D Nelson; George J Schwartz; Victoria Velazquez; Logan A Walker; Xi Chen; Pearlly Yan; David S Hains; Andrew L Schwaderer
Journal:  Sci Rep       Date:  2019-01-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.